Sort
48,018 grants matching “immunotherapy”
Repurposing Glucosylceramide Synthase to Promote Mitochondrial Lethality and Potentiate an Anti-Tumor Immune Response in Triple-Negative Breast Cancer
$480,171Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Deciphering the immunogenicity of cell death using systematic genetic tools
$480,151Roarke Alexander Kamber · University Of California, San Francisco · DP2 · FY2025 · AI
Targeting the LIFR-LCN2 pathway to improve liver cancer therapy
$480,131Li Ma · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Targeting the LIFR-LCN2 pathway to improve liver cancer therapy
$480,131Li Ma · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections
$480,128Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Cellular Transduction with Replication-Competent Retrovirus Vectors
$480,116Noriyuki Kasahara · University Of California Los Angeles · R01 · FY2007 · CA
Mechanisms by which effector T cells modulate endogenous remyelination
$480,107Peter A Calabresi · Johns Hopkins University · R01 · FY2024 · NS
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES
$480,093Warren S Pear · University Of Pennsylvania · T32 · FY2017 · CA
Role of the DR/DQ super enhancer in MHC-II expression
$480,092Jeremy M. Boss · Emory University · R01 · FY2021 · AI
Role of the DR/DQ super enhancer in MHC-II expression
$480,092Jeremy M. Boss · Emory University · R01 · FY2023 · AI
Role of the DR/DQ super enhancer in MHC-II expression
$480,092Jeremy M. Boss · Emory University · R01 · FY2024 · AI
Role of the DR/DQ super enhancer in MHC-II expression
$480,092Jeremy M. Boss · Emory University · R01 · FY2022 · AI
Cellular mechanisms by which exhausted T cell responses are restored
$480,042Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2022 · AI
DYSBIOTIC MICROBIOME IN PANCREATITIS, DIABETES, AND PANCREATIC CANCER
$480,038William E Fisher · Baylor College Of Medicine · U01 · FY2021 · DK
CAR T CELLS ENGINEERED TO KILL HIV-INFECTED CELLS WHILE SECRETING BROADLY NEUTRALIZING ANTIBODIES
$480,000Brian Lawson · Scintillon Institute For Photobiology · R01 · FY2021 · AI
DYSBIOTIC MICROBIOME IN PANCREATITIS, DIABETES, AND PANCREATIC CANCER
$480,000William E Fisher · Baylor College Of Medicine · U01 · FY2020 · DK
CAR T CELLS ENGINEERED TO KILL HIV-INFECTED CELLS WHILE SECRETING BROADLY NEUTRALIZING ANTIBODIES
$480,000Brian Lawson · Scintillon Institute For Photobiology · R01 · FY2022 · AI
CAR T CELLS ENGINEERED TO KILL HIV-INFECTED CELLS WHILE SECRETING BROADLY NEUTRALIZING ANTIBODIES
$480,000Brian Lawson · Scintillon Institute For Photobiology · R01 · FY2024 · AI
CAR T CELLS ENGINEERED TO KILL HIV-INFECTED CELLS WHILE SECRETING BROADLY NEUTRALIZING ANTIBODIES
$480,000Brian Lawson · Scintillon Institute For Photobiology · R01 · FY2023 · AI
DYSBIOTIC MICROBIOME IN PANCREATITIS, DIABETES, AND PANCREATIC CANCER
$480,000William E Fisher · Baylor College Of Medicine · U01 · FY2023 · DK
DYSBIOTIC MICROBIOME IN PANCREATITIS, DIABETES, AND PANCREATIC CANCER
$480,000William E Fisher · Baylor College Of Medicine · U01 · FY2022 · DK
Impact of RB activation on the pancreatic cancer epigenome and tumor microenvironment
$479,955Agnieszka Witkiewicz · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
UPIT: Unleash the Potential of Intestinal Transplantation
$479,946Alexander Helmut Kurt Kroemer · Georgetown University · R01 · FY2018 · AI
UPIT: Unleash the Potential of Intestinal Transplantation
$479,946Alexander Helmut Kurt Kroemer · Georgetown University · R01 · FY2019 · AI
UPIT: Unleash the Potential of Intestinal Transplantation
$479,946Alexander Helmut Kurt Kroemer · Georgetown University · R01 · FY2021 · AI